In the news: MM+M | Lirio Named a Top AI Pharma Marketing Tool That Works
MM+M highlights Lirio as a top AI-powered pharma marketing tool, showcasing how Precision Nudging® drives real patient engagement and behavior change.
MM+M highlights Lirio as a top AI-powered pharma marketing tool, showcasing how Precision Nudging® drives real patient engagement and behavior change.
New research shows why AI investments aren’t translating into better patient engagement—and how N-of-1 personalization could help health systems close the gap.
Lirio, the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives, is proud to announce its inclusion on the Inc. Best in Business list. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impact on their industries.
Lirio, the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives, today released a report based on in-depth surveys with more than 75 executives from U.S. health systems, independent hospitals, and physician groups, showing more than half of healthcare organizations struggle to customize patient outreach content.
Lirio, the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives, today announced the launch of its solution, Precision Nudging® for Life Sciences, developed to help pharmaceutical and biotechnology companies deliver adaptive, behaviorally informed messaging directly to patients and caregivers across every stage of the treatment journey.
Lirio’s AI-driven Precision Nudging® solution is now available in Microsoft Marketplace, enabling healthcare organizations to deploy hyper-personalized behavioral interventions directly within Microsoft’s secure cloud ecosystem.